Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.000
+0.105 (5.54%)
At close: Mar 6, 2026, 4:00 PM EST
1.960
-0.040 (-2.00%)
After-hours: Mar 6, 2026, 7:57 PM EST

Editas Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1951058275971,7964,335
Upgrade
Market Cap Growth
14.85%-87.33%38.68%-66.78%-58.56%188.64%
Upgrade
Enterprise Value
49-1224161391,1683,820
Upgrade
Last Close Price
2.001.2710.138.8726.5570.11
Upgrade
PS Ratio
4.213.2410.5930.2770.3147.77
Upgrade
PB Ratio
13.870.782.371.653.2411.01
Upgrade
P/TBV Ratio
14.510.782.371.653.2411.01
Upgrade
EV/Sales Ratio
1.06-5.327.0745.7142.10
Upgrade
Debt / Equity Ratio
1.460.260.110.120.050.07
Upgrade
Net Debt / Equity Ratio
-10.85-1.75-1.12-1.09-1.07-1.23
Upgrade
Net Debt / EBITDA Ratio
1.301.012.401.793.163.71
Upgrade
Net Debt / FCF Ratio
0.811.072.852.173.462.60
Upgrade
Asset Turnover
0.180.080.150.030.040.17
Upgrade
Quick Ratio
2.813.715.275.8110.677.01
Upgrade
Current Ratio
2.863.755.395.9410.827.20
Upgrade
Return on Equity (ROE)
-211.37%-98.10%-43.17%-48.22%-40.64%-35.36%
Upgrade
Return on Assets (ROA)
-28.26%-35.52%-20.87%-23.70%-19.31%-15.58%
Upgrade
Return on Capital Employed (ROCE)
-85.50%-90.40%-38.80%-49.70%-30.60%-26.20%
Upgrade
Earnings Yield
-102.35%-226.16%-18.52%-36.95%-10.72%-2.68%
Upgrade
FCF Yield
-92.56%-209.00%-16.55%-30.42%-9.56%-4.31%
Upgrade
Buyback Yield / Dilution
-3.57%-8.39%-10.63%-1.55%-15.37%-17.26%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.